United Therapeutics Corporation (UTHR)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,444,000 | 5,984,800 | 4,796,700 | 3,958,900 | 3,395,200 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $6,444,000K)
= 0.00
United Therapeutics Corporation has consistently maintained a debt-to-capital ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt financing to fund its operations and investments during this period. A debt-to-capital ratio of 0.00 typically suggests that the company's capital structure is primarily composed of equity rather than debt, reflecting a lower financial risk and a strong financial position. It implies that United Therapeutics has primarily used its own funds or equity to support its operations and growth, which may be viewed positively by investors and creditors.
Peer comparison
Dec 31, 2024